利伐沙班片的作用与功效

Rivaroxaban mainly has an anticoagulant effect. It is an oral anticoagulant drug that mainly exerts an anticoagulant effect by selectively inhibiting the activity of factors. Clinically, it can be mainly used to prevent the formation of venous thrombosis. It can also be used to treat the formation of deep vein thrombosis and pulmonary embolism in adults. At the same time, it can also be used in patients with non-valvular atrial fibrillation to reduce the risk of stroke and systemic embolism.

In short, it mainly has an anticoagulant effect. Under the conditions of good control with warfarin therapy, compared with warfarin, the current treatment data of rivaroxaban in stroke and systemic embolism are still relatively limited. However, as the clinical application of the drug gradually increases, its evidence will gradually be enriched.

Rivaroxaban is a highly selective, oral drug that directly inhibits factor Xa. By inhibiting factor A dose-dependent inhibition of factor Xa activity by rivaroxaban has been observed in humans. The effect of rivaroxaban on prothrombin time (PT) has a dose-effect relationship. If NeopLastin is used for content measurement, it is closely related to the plasma concentration (correlation coefficient is 0.98).

It was officially approved for sale in China in March 2009, and has also been included in the national medical insurance to provide everyone with government discounts to reduce the financial burden. But even after medical insurance, the price of rivaroxaban remains high, prohibiting many families. However, according to what Medical Companion Travel has learned, the most popular one on the market is Germany's Bayer's rivaroxaban, which is priced at only $350 for 20mg*28 tablets. Compared with other versions, this version is more cost-effective and more suitable for long-term use by patients. Since the exchange rate has been in a state of fluctuation for a long time, the price fluctuates with the exchange rate and is not static. For more information about rivaroxaban, please contact Medical Companion Travel for details.

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.